BNP Paribas Financial Markets’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.58M Buy
147,343
+40,190
+38% +$311K ﹤0.01% 2999
2026
Q1
$683K Sell
107,153
-197,475
-65% -$1.37M ﹤0.01% 3412
2025
Q4
$2.14M Sell
304,628
-81,550
-21% -$492K ﹤0.01% 2574
2025
Q3
$2.12M Buy
386,178
+93,144
+32% +$456K ﹤0.01% 2573
2025
Q2
$1.51M Buy
293,034
+4,494
+2% +$26.9K ﹤0.01% 2654
2025
Q1
$1.92M Buy
288,540
+169,698
+143% +$1.29M ﹤0.01% 2388
2024
Q4
$876K Buy
+118,842
New +$853K ﹤0.01% 2915

Other funds holding LFST

BNP Paribas Financial Markets's LFST Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its Lifestance Health (LFST) stake by 38% in Q2 2026, buying an estimated $311K and bringing the position to 147,343 shares worth $1.58M. The position accounts for ﹤0.01% of the portfolio, ranked #2999.

BNP Paribas Financial Markets first reported a position in LFST in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.14M in Q4 2025. 265 funds tracked by Wall St. Rank hold LFST as of Q2 2026.

  • BNP Paribas Financial Markets held 147,343 shares of Lifestance Health worth $1.58M as of Q2 2026.
  • BNP Paribas Financial Markets bought 40,190 Lifestance Health shares in Q2 2026, an estimated $311K.
  • Lifestance Health made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #2999 holding.
  • BNP Paribas Financial Markets first reported a position in Lifestance Health in Q4 2024 and has held it in 7 quarters since.
  • BNP Paribas Financial Markets's Lifestance Health position peaked at $2.14M in Q4 2025.
  • 265 funds tracked by Wall St. Rank held Lifestance Health as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.